Clinical Trials Browser

Phase 1/2 × Colonic Neoplasms × 5-aminolevulinic acid hexyl ester × Clear all

NCT01344902 2013-10-23

An Open Dose-finding Study of Oral Applied Hexaminolevulinate (HAL) Imaging in Patients With Suspicion or High Risk of Neoplasia in the Colon

Phase 1/2 Terminated

Gastrointestinal

Colonic Neoplasms